Updated Jul 16, 2026
Mainolfi Nello has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $34.88M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 50.0K | $119.00 | $5.95M |
| 2026-07-08 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise | 50.0K | $2.08 | $104K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 3.3K | $116.56 | $389K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 44.0K | $115.69 | $5.10M |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 24.1K | $114.96 | $2.77M |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 6.6K | $113.98 | $755K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 1.9K | $112.80 | $212K |
| 2026-07-02 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise | 80.0K | $2.08 | $166K |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 936 | $82.45 | $77K |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 12.1K | $81.70 | $985K |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale | 17.0K | $80.74 | $1.37M |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise | 30.0K | $2.08 | $62K |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale [10b5-1] | 8 | $93.49 | $748 |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.5K | $92.81 | $139K |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.3K | $91.76 | $302K |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale [10b5-1] | 5.4K | $90.39 | $491K |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale [10b5-1] | 19.8K | $89.78 | $1.77M |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise [10b5-1] | 30.0K | $2.08 | $62K |
| 2026-01-06 | KYMR | Kymera Therapeutics, Inc. | M — Option exercise | 3.1K | $32.07 | $100K |
| 2025-12-31 | KYMR | Kymera Therapeutics, Inc. | S — Open-market sale [10b5-1] | 6.0K | $78.52 | $472K |
Mainolfi Nello is a corporate insider — currently tracked as Insider of Kymera Therapeutics, Inc. (KYMR). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 21 open-market sales ($34.88M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mainolfi Nello profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.